Emendo Biotherapeutics

Provider of re-designed gene-editing tools as drugs for genetic disorders

placeNess Ziona, Center District, Israel calendar_todayFounded 2015 groups116 employees language emendobio.com

Social engagement

Social engagement: 5.4K social following, 1 post in the last 12 months — around the industry typical range.

Investor mix

3 investors on record; lead investors include AnGes.

Investor typeCountShare
Venture capital267%
Other / undisclosed133%

Recent activity

3 May 2026
Event
ASGCT 2026
Coming soon